Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 7, 2015, Pages 1613-1620

  Muhanna, Nidal ^a,b,c   Mepham, Adam ^d   Mohamadi, Reza M ^c   Chan, Harley ^a   Khan, Tahsin ^a   Akens, Margarete ^a   Besant, Justin D ^d   Irish, Jonathan ^a,b,c   Kelley, Shana O ^c,d,e  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cell sorting; Circulating tumor cells; Microfluidics; Nanoparticle; Rabbit cancer model

Indexed keywords

ANIMALS; BIOMOLECULES; CELL ADHESION; COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; DISEASES; MICROFLUIDICS; MOLECULES; NANOPARTICLES; TUMORS;

ANTIGEN EXPRESSION; CANCER MODELING; CELL SORTING; CIRCULATING TUMOR CELLS; DISEASE PROGRESSION; EPITHELIAL CELL ADHESION MOLECULES; LYMPH NODE METASTASIS; TUMOR PROGRESSIONS;

CELLS;

EPITHELIAL CELL ADHESION MOLECULE; EPITHELIAL MEMBRANE ANTIGEN; NANOPARTICLE; CELL ADHESION MOLECULE; TUMOR ANTIGEN; TUMOR-ASSOCIATED ANTIGEN GA733;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL SELECTION; CIRCULATING TUMOR CELL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; LYMPH NODE METASTASIS; NONHUMAN; PRIMARY TUMOR; TUMOR CELL LINE; TUMOR GROWTH; TUMOR VOLUME; ANIMAL; BLOOD; CELL TRACKING; CHEMISTRY; DISEASE COURSE; DISEASE MODEL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; METABOLISM; NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS; RABBIT; TUMOR EMBOLISM;

ANIMALS; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL TRACKING; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LYMPHATIC METASTASIS; NANOPARTICLES; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; RABBITS; TUMOR BURDEN;

EID: 84942109005     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2015.04.017     Document Type: Article

References (30)

1. Quirke P., Williams G.T., Ectors N., Ensari A., Piard F., Nagtegaal I. The future of the TNM staging system in colorectal cancer: time for a debate?. Lancet Oncol 2007, 8:651-657.
2. Baxter N.N., Tuttle T.M. Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol 2005, 12:981-987.
3. Schnipper L. Clinical implications of tumor-cell heterogeneity. N Engl J Med 1986, 14:1423-1431.
4. Junttila M.R., de Sauvage F.J. Influence of tumor micro-environment heterogeneity on therapeutic response. Nature 2013, 501:346-354.
5. Aceto N., Bardia A., Miyamoto D.T., Donaldson M.C., Wittner B.S., Spencer J.A., et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 2014, 158:1110-1122.
6. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454.
7. Heitzer E., Auer M., Gasch C., Pichler M., Ulz P., Hoffmann E.M., et al. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res 2013, 73:2965-2975.
8. Zong C., Lu S., Chapman A.R., Xie X.S. Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science 2012, 338:1622-1626.
9. Cohen S.J., Punt C.J., Iannotti N., Saidman B.H., Sabbath K.D., Gabrail N.Y., et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008, 26:3213-3221.
10. Cristofanilli M., Budd G.T., Ellis M.J., Stopeck A., Matera J., Miller M.C., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004, 351:781-791.
11. Bidard F.C., Mathiot C., Delaloge S., Brian E., Giachetti S., de Cremoux P., et al. Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann Oncol 2010, 21:729-733.
12. Chaffer C.L., Weinberg R. A perspective on cancer cell metastasis. Science 2011, 331:1559-1564.
13. Yu M., Bardia A., Wittner B.S., Stott S.L., Smas M.E., Ting D.T., et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013, 339:580-584.
14. Gorges T.M., Tinhofer I., Drosch M., Röse L., Zollner T.N., Krahn T., et al. Circulating tumor cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer 2012, 12:178.
15. Tsukamoto H., Shibata K., Kajiyama H., Terauchi M., Nawa A., Kikkawa F. Irradiation-induced epithelial-mesenchymal transition (EMT) related to invasive potential in endometrial carcinoma cells. Gynecol Oncol 2007, 107:500-504.
16. Nagrath S., Sequist L.V., Maheswaran S., Bell D.W., Irimia D., Ulkus L., et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450:1235-1239.
17. Nichols A.C., Lowes L.E., Szeto C.C.T., Basmaji J., Dhaliwal S., Chapeskie C., et al. Detection of circulating tumor cells in advanced head and neck cancer using the Cell Search system. Head Neck 2012, 34:1440-1444.
18. Rao C., Bui T., Connelly M., Doyle G., Karydis I., Middleton M.R., et al. Circulating melanoma cells and survival in metastatic melanoma. Int J Oncol 2011, 38:755-760.
19. Bidard F.C., Ferrand F.R., Huguet F., Hammel P., Louvet C., Malka D., et al. Disseminated and circulating tumor cells in gastrointestinal oncology. Crit Rev Oncol Hematol 2012, 82:103-115.
20. Naoe M., Ogawa Y., Morita J., Omori K., Takeshita K., Shichijyo T., et al. Detection of circulating urothelial cancer cells in the blood using the Cell Search system. Cancer 2007, 109:1439-1445.
21. Mohamadi R.M., Besant J.D., Mepham A., Green B., Mahmoudian L., Gibbs T., et al. Nanoparticle-mediated binning and profiling of heterogeneous circulating tumor cell subpopulations. Angew Chem Int Ed 2015, 54:139-143.
22. Besant J.D., Mohamadi R.M., Aldridge P.M., Li Y., Sargent E.H., Kelley S.O. Velocity valleys enable efficient capture and spatial sorting of nanoparticle-bound cancer cells. Nanoscale 2015, 7:6278-6285.
23. Cristofanilli M., Broglio K.R., Guarneri V., Jackson S., Fritsche H.A., Islam R., et al. Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clin Breast Cancer 2007, 7:34-42.
24. Alix-Panabières C., Pantel K. Circulating tumor cells: liquid biopsy of cancer. Clin Chem 2013, 59:110-118.
25. McGale P., Taylor C., Correa C., Cutter D., Duane F., et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 2014, 283:2127-2135.
26. Baum B., Settleman J., Quinlan M.P. Transitions between epithelial and mesenchymal states in develoment and disease. Semin Cell Dev Biol 2008, 19:294-308.
27. Hiltermann R.J., Pore M.M., van den Berg A., Timens W., Boezen H.M., Liesker J.J., et al. Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. Ann Oncol 2012, 23:2937-2942.
28. Steinert G., Schölch S., Niemietz T., Iwata N., García S.A., Behrens B., et al. Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer. Cancer Res 2014, 74:1694-1704.
29. Wang D., Bodovitz S. Single cell analysis: the new frontier in 'omics'. Trends Biotechnol 2010, 28:281-290.
30. Joosse S.A., Pantel K. Biologic challenges in the detection of circulating tumor cells. Cancer Res 2013, 73:8-11.